✌(-‿-)✌ try 1ClickPost.com paste text to share free

FDA Approval in AML, NDA Submitted in Myeloma, Clinical Hold on CAR T-cell Therapy Trials, and More

Say and pronounce FDA Approval In on SuperTTS.com Make Your Own Text-To-Speech Words Instantly

  Info

Description

Gina Columbus reports on an FDA approval in acute myeloid leukemia, a new drug application submitted in multiple myeloma, encouraging results in a chronic lymphocytic leukemia trial, a delayed decision on a biosimilar, a clinical hold on CAR T-cell therapy trials, and a European approval in bladder cancer.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
Old Cartoons on DVD. Visit and Bookmark: Cool90s.com!

Related

  FDA Approval in ALL, Priority Reviews in CML and Breast Cancer, and More   Clinical Hold Lifted in AML, and Encouraging Phase III Findings in Myeloma, CLL, and Breast Cancer   Breakthrough Therapy Designation in CSCC, 2017 ESMO Congress Highlights, and More   Some FDA-approved drugs had safety issues later   Alix Beaupierre on Patient Education for CAR T-Cell Therapy Clinical Trials   FDA Approval in Carcinoid Syndrome Diarrhea, Priority Reviews in Bladder Cancer and NSCLC, and More   Dr. Voorhees on Pivotal Ongoing Trials in Multiple Myeloma   FDA pulls Keytruda from two clinical trials after deaths   Review on 2016 FDA Approvals, Halt on AML Trials, and More   FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights   Unmet Needs in Systemic Therapy for Liver Cancer   Dr. Erba on the FDA Approval of CPX-351 in AML   FDA Approves Rydapt For Adults With AML   FDA Approvals in Breast Cancer and Hodgkin Lymphoma, 2017 SGO Highlights, and More   How Does The FDA Approve New Drugs?   FDA Approval Sought in Multiple Myeloma, 2017 AACR Annual Meeting Highlights, and More   Vivek Ramaswamy On Getting An Alzheimer's Drug Approved | Forbes   Vivek Ramaswamy On Getting An Alzheimer's Drug Approved | Forbes   What's next in fighting cancer with polio virus?   Dr. Al-Kali on FDA Approval of Enasidenib in AML   FDA Approvals in GVHD, CRC, and AML, a Priority Review in MCL, and More   Evidence With SIRT in HCC   FDA Approvals in Hematologic Malignancies, sBLA Accepted in Multiple Myeloma, and More   Cancer Advance of the Year, FDA Approval for CINV, Breakthrough Designation in TNBC, And More   FDA Approval in Lung Cancer, Promising Findings in Hodgkin Lymphoma, and More   FDA Approval in AML, Priority Review Designation in NSCLC, and More   FDA Approval in Breast Cancer, Breakthrough Designations in AML and Bladder Cancer, and More   Cancer treatment breakthrough with immune cells, explained   Mayo Clinic Cancer Center Gene and Virus Therapy Shared Resource: A Virtual Tour   What Does 'Clinically Proven' Actually Mean?   Dr. Kumar on Potential of CAR T-Cell Therapy in Multiple Myeloma   Research into Cancer Treatments   FDA Approvals in Breast Cancer and NSCLC, NDA Accepted in HCC, and More   FDA Approval in Bladder Cancer, Breakthrough Therapy Designation in DLBCL, and More   Expert: New Women's Sex Drug 'A Step Forward'   FDA approves breakthrough CAR-T therapy for leukemia   Dr. Jagannath on CAR T-Cell Therapy for Multiple Myeloma   Nivolumab Lung Cancer Approval Expanded, Abemaciclib Granted Breakthrough Status, and More   New balloon capsule could take bite out of obesity   Dr. Fanale on Clinical Trials for T-Cell Lymphoma   Niraparib Maintenance for Recurrent Ovarian Cancer   Ongoing Neoadjuvant Clinical Trials in Pancreatic Cancer   First- and Later-line Use of Panitumumab in Metastatic Colorectal Cancer   FDA Approvals in NSCLC, Bladder Cancer, and Breast Cancer, and Death in CAR T-cell Therapy Trial   Promising Parkinson's research in San Diego   Choosing Triplet Therapy at Myeloma Relapse   New cancer treatment offers patients hope   Dr. Siefker-Radtke on FDA Approval of Frontline Atezolizumab in Bladder Cancer   Clinical Experience: CDK4/6 Inhibitors in Breast Cancer   UK Researchers, Participants Dispel the Myths of Clinical Trials   FDA Approvals for Daratumumab and Osimertinib, Regulatory Advances in RCC and CLL, and More   CAR T-Cell Therapy for Multiple Myeloma   Patients Call Participating in Clinical Trials at UK "Empowering"   Full FDA Approvals in Breast Cancer and Lung Cancer, Priority Reviews in ALL, and More   FDA Approves Treatment for Childhood Leukemia   Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast Cancer   FDA endorses cancer therapy done in Nebraska Medicine trials   Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Breast Cancer   Understanding Clinical Trials: Mayo Clinic Radio   Update: Clinical Trials Using Stem Cells for Treatment of ALS at Mayo Clinic   FDA Approvals, Breakthrough Designations, Priority Reviews, and More   American Lives Extended By Over 3 Million Years Because Of This   Why Clinical Trials Are So Important at the University of Kentucky   Transplant and Maintenance Therapy in Multiple Myeloma   ReNeuron 'greatly encouraged' by US regulator feedback on CTX cell therapy trial   Personalised medicine could lead to a breakthrough in cancer in 2017   Testosterone Treatment Boosts Bone Density And Arterial Plaque   ఫార్మా కంపెనీల చెలగాటం..! | తెలుగు రాష్ట్రాల్లో సంచలనం రేపుతున్న క్లినికల్ ట్రయల్స్ | TV5 News   Dr. Roboz on Advancements on the Horizon in AML   Gilead to Acquire Biotech Company Kite Pharma Pharma   Monoclonal Antibody Therapy in Myeloma   A Highly Effective Cancer Treatment Has Just Been Approved by the FDA   Clinical Trials in Breast Cancer   You Can Make a Difference   Dr. Kumar on Recent Advancements in the Field of Multiple Myeloma

Popular Today